@article{discovery10203927,
            year = {2025},
         journal = {Rheumatology},
       publisher = {Oxford University Press (OUP)},
           month = {January},
            note = {Copyright {\copyright} The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.},
           title = {Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort},
          author = {Roth, Eliane and Bruni, Cosimo and Petelytska, Liubov and Becker, Mike Oliver and Dobrota, Rucsandra and Jordan, Suzana and Mihai, Carina and Muraru, Sinziana and Carreira, Patricia E and De Vries-Bouwstra, Jeska and Braun-Moscovici, Yolanda and Liakouli, Vasiliki and Moroncini, Gianluca and Bergmann, Christina and Mouthon, Luc and Denton, Christopher P and De Santis, Maria and Cauli, Alberto and Adler, Sabine and Bernardino, Vera and Truchetet, Marie-Elise and Vonk, Madelon and Del Galdo, Francesco and Hoffmann-Vold, Anna-Maria and Distler, Oliver and Elhai, Muriel and EUSTAR collaborators, {}},
            issn = {1462-0324},
             url = {https://doi.org/10.1093/rheumatology/keaf016},
        abstract = {OBJECTIVES: Gastroesophageal reflux disease (GERD) is frequent in systemic sclerosis (SSc) and could predict progression of interstitial lung disease (ILD). We aimed to analyse (1) the prevalence of GERD among SSc-ILD patients, (2) its association with disease characteristics and (3) predictive factors for ILD progression in SSc-ILD patients with GERD. METHODS: SSc patients from the EUSTAR database with ILD were included. GERD was labeled as present if reflux/dysphagia was reported at the baseline visit or before. Disease characteristics of patients with and without GERD were compared at baseline. ILD progression was defined as relative FVC decline {$\ge$}10\% or relative FVC decline between 5-9\% in association with relative DLCO decline of {$\ge$} 15\% over 12{$\pm$}3 months of follow-up. Prognostic factors for ILD progression, overall survival and progression-free survival in SSc-ILD patients with GERD were tested by multivariable Cox regression. RESULTS: 5462 SSc-ILD patients were included, 4400 (80.6\%) had GERD. Patients with GERD presented more frequently with diffuse cutaneous SSc (OR: 1.44 [1.22-1.69], p {\ensuremath{<}} 0.001) and more severe lung involvement with lower FVC (85.8{$\pm$}22.1 vs 90.2{$\pm$}20.1, p {\ensuremath{<}} 0.001), lower DLCO (60.8{$\pm$}19.7 vs 65.3{$\pm$}20.6, p {\ensuremath{<}} 0.001) and worse performance at the 6-minute walking test. Female sex (HR: 1.39 [1.07-1.80], p = 0.012) and older age (HR: 1.02 [1.01-1.03], p {\ensuremath{<}} 0.001) independently predicted ILD progression in SSc-ILD patients with GERD. CONCLUSION: SSc-ILD patients with GERD appear to suffer from a more severe SSc disease. In this population, female sex may be considered as risk factor for ILD progression.},
        keywords = {gastroesophageal reflux disease, interstitial lung disease, progression, systemic sclerosis}
}